Study S001822

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07017270
Acronym: GUARD-1
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: RECRUITING
Enrollment: 100
Start: 2025-11-27
Primary completion: 2027-07
Lead sponsor: Unity Health Toronto
Conditions: Kidney Disease, Chronic; Diabetes; Dialysis; End Stage Kidney Disease (ESRD)
Interventions: DRUG:Semaglutide Pen
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Adherence of Study Intervention [26 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.